Literature DB >> 30410083

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.

Ioanna Sakellari1, Eleni Gavriilaki2, Stella Bouziana1, Varnavas Constantinou1, Despina Mallouri1, Anna Vardi1, Anastasia Marvaki1, Ioannis Batsis1, Damianos Sotiropoulos1, Achilles Anagnostopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30410083     DOI： 10.1038/s41409-018-0395-y

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.

Authors:  Rui Huang; Xiwen Liao; Xiangkun Wang; Qiaochuan Li
Journal:  J Cancer       Date:  2021-02-21       Impact factor: 4.207

2.  Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin's lymphoma patients.

Authors:  Chen Tian; Yueyang Li; Su Liu; Zehui Chen; Yizhuo Zhang; Yong Yu; Hongliang Yang; Haifeng Zhao; Zhigang Zhao; Tian Yuan; Yafei Wang
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

3.  Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study.

Authors:  Hongnan Mo; Peng Liu; Yan Qin; Xiaohui He; Xiaohong Han; Jiarui Yao; Weicai Su; Shuxiang Zhang; Le Tang; Fengyi Zhao; Lin Gui; Sheng Yang; Jianliang Yang; Shengyu Zhou; Zhishang Zhang; Yuankai Shi
Journal:  Chronic Dis Transl Med       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.